Tuesday, November 17, 2026

HVC KYOTO 2023 DemoDay! 22 startups announced to challenge overseas markets in healthcare!

The Japan External Trade Organization (JETRO) and Kyoto Research Park, in collaboration with Kyoto Prefecture and Kyoto City, will hold a two-day DemoDay for HVC KYOTO 2023, an innovation platform specializing in the healthcare sector, from July 6 to 7, 2023!
HVC KYOTO has been working with overseas universities, VC/incubators, and startups since its inception in 2016 to produce startups that are active in the healthcare field on the global stage, not just in Japan, and has conducted pitches entirely in English. and "Medtech" categories, with 22 startups selected. During the event, the startups will pitch to global pharmaceutical companies participating as advisors and partners, and will also have the opportunity to conduct individual business meetings.

The Shape of Innovation Envisioned by HVC KYOTO in its Eighth Year

HVC KYOTO (Healthcare Venture Conference KYOTO) is an "innovation platform" for startups and entrepreneurial-minded researchers in the healthcare field aiming for overseas expansion, as well as business companies, investors, incubators, etc. who are actively involved in Open Innovation and support them, to collaborate and enhance each other. The Healthcare Venture Conference KYOTO is an "innovation platform" for startups and entrepreneurial-minded researchers in the healthcare field aiming for overseas expansion, as well as business companies, investors, incubators, and others active in Open Innovation who support them, to collaborate and enhance each other.

Among the year-round programs, the annual DemoDay in July has been held entirely in English, with the aim of launching into the global market. A total of 140 pitches have been made in the past seven sessions. After their presentations at the DemoDay, the speakers have gone on to achieve remarkable success, including major business partnerships, various awards, and fundraising.

This year, 22 startups were selected in two new divisions, Biotech and Medtech. Experts from each division were invited to serve as advisors. In response to the growing global interest in the seeds of medical devices and digital health and the increase in entries to HVC KYOTO, we have strengthened our support for the selected startups and made more professional mentoring available to them.

About DemoDay

This year's DemoDay will be joined at the local venue in Kyoto by overseas guests, including a professor from Stanford University and an expert from a foreign pharmaceutical company, following the relaxation of Corona measures. Day 1 will feature individual business meetings between partner operating companies and startups, as well as a reception party to experience HVC KYOTO's innovation platform; Day 2 will feature pitches and keynote speeches, providing an opportunity to experience the latest knowledge and technology. The general public can view the recorded video of the second day only at a later date by applying in advance.

~DemoDay is recommended for the following people
Management and planning departments of large companies interested in partnering with startups
VCs and CVCs who want to explore startups for investment
・Researchers in academia who aim to start their own business in the future.
Those in industry-academia collaboration departments who wish to promote technology transfer at universities

Adopted Startups

This year, 22 startups were selected from the large number of applications received, and 10-15 companies will pitch at the DemoDay. The Biotech category is mainly for drug discovery, biotechnology, and regenerative medicine, while the Medtech category is mainly for digital health and medical devices.

Program Director Haruka Hashimoto comments

Implement and enjoy excellent research results in society.
In the process of achieving this common mission, there is joint research in industry and academia and the establishment of university-launched startups. However, the startup ecosystem in the life science field, including all of the above, still faces challenges in terms of people, products, and money. Under these circumstances, in recent years in Japan, non-IPO EXIT strategies such as Kaken Pharmaceutical's M&A of ARTham Therapeutics have been chosen, and there are signs of an increase in technology licensing and asset out-licensing agreements. In addition, foreign companies are signing large contracts with Japanese universities and start-up seeds.
There is a word that expresses the spirit of the tea ceremony, "harmony and respect," which indicates mutual openness and respect for each other.
This is a spirit that is highly compatible with the startup industry, where individual enthusiasm and drive are particularly important in creating opportunities for collaboration, establishing and executing investments, and promoting business. We believe that it is necessary to sublimate the relationship to one in which each stakeholder opens his/her heart and reveals what skills he/she can offer and what his/her company cannot do.

HVC KYOTO, now in its 8th year, holds advice sessions in May and June, where startups, companies, and investors share their challenges and discuss how to move their businesses forward, and a Demo Day in July, where the attractiveness of startups is widely communicated and a new section, "Pitch Day," is held. The goal of this new section is to provide an opportunity for companies and investors to discuss business expectations, exit strategies, awareness of issues, and draft solutions in response to the pitches, thereby strengthening collaboration among ecosystem players and increasing the number of academics interested in the startup industry and corporate employees who raise their hands to become potential managers.
In addition, through the creation of two divisions, Biotech and Medtech, we will strive to present to the market a more realistic reflection of the current status of seed creation.
We hope that HVC KYOTO will play a role in the evolution of the ecosystem and contribute to the social implementation of excellent research results.

<Haruka Hashimoto Biography
Representative Director, Convallaria Inc.
He invests in and supports startups, focusing on biotechnology, healthcare, agriculture, and IT. The company focuses on biotechnology, healthcare, agriculture, and IT, and is also developing the Seeds-Hub, a platform for matching university seeds with the needs of business companies, in cooperation with Kyoto University and others.
Prior to his current position, he worked at DeNA New Business and Digital Garage, where he invested in domestic and international bio/healthcare businesses and launched acceleration programs. M.S. in Applied Life Sciences, Graduate School of Agriculture, Kyoto University

Lead Advisor Tomoyoshi Koyanagi Message

What does success mean for a healthcare startup?
I believe that, in addition to economic success, another major success is the creation of a group of people who continue to work enthusiastically to address and solve social health issues such as patients who are suffering from lack of treatment and this pandemic.
In 2023, HVC KYOTO will transition to a year-round community to further share the experiences of the past seven events. The DemoDay will be a great opportunity to promote the companies on the panel and explore ways to grow together in the global marketplace.

.
Director, Business Development Office, Institute for Advanced Medical Research and Development (iACT), Kyoto University Hospital, Specified Professor
"HVC KYOTO" (started in 2016), "Research Studio powered by SPARK" (started in 2018), and other medical startups from academia. He has been involved in many training programs for medical startups from academia. He studied at Stanford University under Professor Mochly-Rosen, who founded SPARK, an educational program for Translational Research. Since returning to Japan, he has held sales and marketing positions in multinational companies and business development positions in drug discovery and regenerative medicine ventures. He was involved in the creation of several joint ventures and start-ups at Kyoto University and Tsukuba University before assuming his current position in September 2022. He is also a researcher at Tsukuba Clinical Medical Research and Development Organization, University of Tsukuba. He was a member of the first term of the "Startup Next Innovator" program of the Ministry of Economy, Trade and Industry (METI). Graduated from Osaka University.

Outline of the event

Name: HVC KYOTO (Healthcare Venture Conference Kyoto) 2023 DemoDay
Date: Thursday, July 6, 2023 DemoDay 1 (Individual business meeting and reception party)
     Friday, July 7, 2023 DemoDay 2 (Pitch and Keynote)
Venue: KRP Bldg. 4, B1F "Buzz Hall" and others (93 Awata-cho, Shimogyo-ku, Kyoto)
Content: Pitches by selected startups, keynote speeches by domestic and international experts, networking, individual business meetings (for selected startups and partners only)
5. language: English (simultaneous interpretation available)
6. registration for participation and viewing: https://hvckyoto2023.peatix.com
Please register via Peatix for DemoDay 2, which will be recorded and distributed to those who register in advance.
*Please contact the secretariat listed at the end of this document if you are a member of the media and would like to cover the event.
7. Organizers: Japan External Trade Organization (JETRO), Kyoto Prefecture, Kyoto City, Kyoto Research Park Co.

8. Program Director: Haruka Hashimoto (President, Convallaria Inc.)
9. Lead Advisor: Tomoyoshi Koyanagi (Professor and Director, Business Development Office, Institute for Advanced Medical Research and Development (iACT), Kyoto University Hospital)
10. advisor:
Dan Wang Head, Johnson and Johnson Innovation - Asia Pacific
Joe Zheng Head of External Alliance, China Innovation Center of Roche, Roche
Seiichi Inamura, General Manager, Technology Partnering Group, Business Development Department, Chugai Pharmaceutical Co.
Satoshi Ogawa, Partner, TMI Associates Kyoto Office
Mikio Kasahara Business Development Director, Asia Partnering, Roche Pharma Partnering
Shumi Kono, General Manager, Business Planning Department, Kyoto University Innovation Capital Co.
Takeshi Kono Licensing Manager, Business Development & Licensing (Japan & East Asia), Kobe Pharmaceutical Research Laboratories, Nippon Boehringer Ingelheim K.K.
Jun Kusunoki Senior Director of Innovation, Johnson & Johnson Country Lead Japan Early Innovation Partnering
Susumu Satake Coordinator for Industry-Academia Collaboration, Japan External Trade Organization (JETRO) Kyoto Trade Information Center
Masakatsu Noguchi, General Manager, Business Development Department, Sanamedi Corporation
Department of Future Medical Development, Osaka University Hospital, Japan
Jun Yamadera President, Eyes, JAPAN Inc.
11. Keynote Speech:
Daria Mochly-Rosen/PhD, Professor, Stanford University School of Medicine,Founder and co-director, SPARK Translational Research Program/Article: to be coordinated
Harm-Jan Borgeld/Head of Asia Partnering, Roche Pharma Partnering/Title: Innovation from Asia: Global Pharma Perspective
12. co-sponsored by Kansai Innovation Initiative (KSII), the Kyoto University Industry-Academia Collaboration Initiative (SACI), and Kyoto University Innovation Capital Co.
13. partner:

Astellas Pharma Inc., WuXi App Tec Japan Inc., JTEKT Corporation, CMIC Healthcare Institute Corporation, Johnson & Johnson Innovation, SCREEN Holdings Corporation, Sumitomo Science and Engineering Co, Ltd., Toyoda Gosei Co., Ltd., Japan Tobacco Inc., Nippon Boehringer Ingelheim Co.
Murata Manufacturing Co., Ltd. also participated in individual business meetings
Kawasaki City Industrial Promotion Foundation, Kyoto University Innovation Capital Corporation, Keio Innovation Initiative (KII), TMI Associates, Tokyu Land Corporation, Sumitomo Mitsui Trust Panasonic Finance Company, Limited, Mitsubishi UFJ Mitsubishi UFJ Capital Co.
*Law firm ZeLo, Foreign Law Joint Enterprise, and PR TIMES, Inc. provide priority infrastructure, back office, and other services as a benefit of participating in the startup.
14. sponsorship:
Kinki Bureau of Economy, Trade and Industry, Osaka Prefectural Government, Hyogo Prefecture, Osaka City, Kobe City, Osaka Chamber of Commerce and Industry, Kyoto Chamber of Commerce and Industry, Kobe Chamber of Commerce and Industry, Kyoto Industry 21 Foundation, Advanced Scientific Technology & Management Research Institute of Kyoto (ASTEM), Kobe Medical Industry Development Organization, Kansai Economic Federation, and Kyoto Industrial Association, Kyoto Knowledge Industry Creation Forest, Life Science Innovation Network Japan (LINK-J), NPO "Kansai Health and Medical Science Liaison Committee", Kansai Pharmaceutical Products Innovation Association (KPIA), NPO Japan MIT Venture Forum (MIT-VF), LLC. (-VF), SARR LLC, Biocommunity Kansai (BiocK)

What is HVC KYOTO?

HVC KYOTO (Healthcare Venture Conference KYOTO) is an "innovation platform" for startups and entrepreneurial-minded researchers in the healthcare field aiming for overseas expansion, as well as business companies, investors, incubators, etc. who are actively involved in Open Innovation and support them, to collaborate and enhance each other. The Healthcare Venture Conference KYOTO is an "innovation platform" for startups and entrepreneurial-minded researchers in the healthcare field aiming for overseas expansion, as well as business companies, investors, incubators, and others active in Open Innovation who support them, to collaborate and enhance each other.
In March 2023, HVC KYOTO was awarded the "IP BASE AWARD" by the Japan Patent Office (JPO) for its outstanding efforts in the field of intellectual property, In March 2023, HVC KYOTO received the "Encouragement Award" in the Ecosystem Category.

What is Kyoto Research Park?

Established in 1989 as the nation's first privately operated science park. It is home to 520 organizations and 6,000 people, including industrial support organizations of Kyoto Prefecture and Kyoto City. In addition to office/laboratory rentals and rental conference rooms, the park offers a variety of activities that lead to the creation of new businesses and industries, such as fostering entrepreneurs, supporting open innovation, and holding seminars and exchange events. The project is called "Emergence Here. ~Under the brand slogan "Paving for New Tomorrow," we contribute to the creation of new businesses that will change the world by providing an attractive stage for exchange and business environment for people around the world who are trying to innovate.

name of companyKyoto Research Park Corporation
EstablishmentOctober 1989
Location134 Chudoji Minami-cho, Shimogyo-ku, Kyoto-shi, Kyoto
representativeAtsuko Kadowaki
uniform resouce locatorhttp://www.krp.co.jp/
PORT Editorial Officehttps://port.creww.me/
PORT by Creww is an open innovation media for startups, entrepreneurs, entrepreneurs in recovery, and companies seeking to create new businesses on the theme of social issues, operated by Creww Co.
- Advertisment -
- Advertisment -

Featured

東芝のオープンイノベーション、協業検討に進む2社が決定 ダイナミックマッププラットフォームとArithmerを選定

ReGACY Innovation Group株式会社(東京都千代田区)は、企画・運営パートナーとして支援する株式会社東芝の「Toshiba OPEN INNOVATION PROGRAM 2026」で、協業検討に進む参加企業2社が決定したと発表した。7月に募集した共創プランの中から、ダイナミックマッププラットフォーム株式会社とArithmer株式会社を選定。両社は東芝グループの「Hybrid-3D LiDAR」と「気象データサービス」を活用し、物流・インフラ分野などでの新たなソリューション共創を目指す。12月中旬の成果発表会に向け、実証と事業性検証を進める。 本プログラムでは、2026年7月6日から7月26日まで参加企業を募集しており、応募のあった共創プランの中から、ダイナミックマッププラットフォーム株式会社、Arithmer株式会社の2社が選定されました。 両社は、東芝グループが保有する「Hybrid-3D LiDAR」および「気象データサービス」の技術・データを用いて、物流・インフラ分野やデータ活用領域における新たなビジネスソリューションの共創を目指します。 今後は、12月中旬に予定されている成果発表会に向けて実証や事業性検証を進めるとともに、事業化を見据えた協業の検討を加速していきます。

新潟日報社、オープンイノベーションプログラム2026ピッチ審査会で「三ツ目」「想ひ人」2社を選定

新潟日報社は8月4日、「新潟日報社 オープンイノベーションプログラム2026 ピッチ審査会」を開催した。Creww株式会社が提供する「Creww Growth」を活用し、5月15日から6月15日にかけて新潟県や社会が抱える課題解決に向けた協業アイデアを募集。応募61件の中から書類審査を通過した8社がピッチに参加し、審査の結果「三ツ目」(新潟県三条市)と「想ひ人」(東京都)の2社を選定した。今後は実証事業等を通じて事業化を進める予定。

【ヤマサキ × BeeInventor】高温下での過酷な作業環境から、データは命を守れるか——創業151年の工業炉建設会社とスマートヘルメット新興企業が挑む「熱中症ゼロ」の現場

明治8年創業の株式会社ヤマサキは、建設業界向けアクセラレータープログラム「ヤマサキ×オープンイノベーションプログラム2024」を通じて、スマートヘルメットを手がけるビーインベンターとのPoCを実施した。内部温度800度を超える製鉄炉の傍らで働く現場作業員の熱中症リスクをAIで早期検知するという挑戦は、今まさに第2フェーズへと移行しようとしている。プロジェクトリーダーの向井裕一氏と、BeeInventor(ビーインベンター)のNao SeoChon氏に話を伺った。

【ヤマサキ × CHAOSRU】「誰も知らない技術」を、誰もが体験できる価値へ——創業151年の工業炉建設会社とVRスタートアップが挑む、採用×認知の壁の壊し方

明治8年創業の株式会社ヤマサキは、製鉄に欠かせない築炉の技術を持ちながら、業界・企業の認知度の壁が採用の課題となっていた。この課題の突破口を探るべく参加したのが、『ヤマサキ×オープンイノベーションプログラム2024』だ。プログラムを通じて、VR・XR技術を核とする株式会社CHAOSRUとの協業をスタート。2025年7月から始まったPoC(実証実験)では、高校生向け採用説明会へのVR体験の導入により、ブース来訪者数に明らかな変化が生まれている。アクセラレータープログラムを通じたスタートアップとの協業で何が動き、何が見えてきたのか。株式会社ヤマサキのプロジェクトリーダー 田中敏彦氏と、CHAOSRU代表取締役の内藤薫氏に話を伺った。